Abstract
At various time intervals following the administration of 1 to 4 mg/kg of 5-bis (2-chloroethyl) aminouracil to rats bearing the Walker 256 carcinosarcoma, 7.5 µc of L-arginine-U-C14 was injected. An hour later, the tissues were excised and the specific activities of the proteins of the intracellular fractions were determined.
The data obtained provide in vivo evidence that the primary site of action of the aminouracil mustard is in the nucleus. The drug particularly affects the systems which are involved in the biosynthesis of the acid insoluble nuclear proteins. This intracellular selectivity of action was demonstrated for the Walker tumor and the spleen which are the biological sites of inhibitory action of this compound. The effect on the spleen was more marked than the effect on the tumor. The drug had virtually no effect on the incorporation of the labeled isotope into the cytoplasmic proteins of the tissues studied.
Footnotes
- Received May 7, 1959.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
